Reported symptoms are similar to those of Ozempic and are likely correlated to changes in blood sugar
Based on the information from drug interaction records, this combination is seen as low risk when taken the right way
ATTAIN-2 enrolled over 1,600 adults with type 2 diabetes and showed meaningful weight reductions of 5.1 to 9.6 percent depending on dose, along with significant improvements in blood sugar control and cardiometabolic markers including waist circumference, blood pressure, and cholesterol
The 1200mg dose provides therapeutic levels that cannot be achieved through oral supplementation due to poor absorption
Long-Term Health Considerations For some individuals, especially those with obesity-related health conditions (like type 2 diabetes, high blood pressure, or cardiovascular issues), staying on GLP-1 medications for the long term might be necessary to manage overall health, not just weight loss
Epithalon activates telomerase to maintain telomere length and support cellular longevity